CIK 0001279704 · Non-accelerated filer<br>Smaller reporting company
Cellectar Biosciences, Inc.
Sign in to watch- Ticker
- CLRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043321804
- Phone
- (608) 441-8120
- Business address
- 100 CAMPUS DRIVE, FLORHAM PARK, NJ, 07932
- Former names
- NOVELOS THERAPEUTICS, INC., COMMON HORIZONS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-02 | Kolean Chad J Chief Financial Officer | Purchase · Warrants | +5,000 | $0.01 | $50 | 5,000 |
| 2025-02-14 | Swirsky Douglas J Director | Grant or award · Stock option (right to buy) | +90,000 | 90,000 | ||
| 2025-02-14 | NEIS JOHN Director | Grant or award · Stock option (right to buy) | +60,000 | 60,000 | ||
| 2025-02-14 | Loren Stefan Director | Grant or award · Stock option (right to buy) | +60,000 | 60,000 | ||
| 2025-02-14 | Longcor Jarrod Chief Operating Officer | Grant or award · Stock option (right to buy) | +500,000 | 500,000 | ||
| 2025-02-14 | Kolean Chad J Chief Financial Officer | Grant or award · Stock option (right to buy) | +290,000 | 290,000 | ||
| 2025-02-14 | DRISCOLL FREDERICK W Director | Grant or award · Stock option (right to buy) | +60,000 | 60,000 | ||
| 2025-02-14 | Chanan-Khan Asher Director | Grant or award · Stock option (right to buy) | +60,000 | 60,000 | ||
| 2025-02-14 | CARUSO JAMES V President and CEO | Grant or award · Stock option (right to buy) | +900,000 | 900,000 | ||
| 2025-01-10 | Longcor Jarrod Chief Operating Officer | Purchase | +30,000 | $0.28 | $8K | 83,141 |
| 2024-06-14 | Longcor Jarrod Chief Operating Officer | Grant or award · Stock option (right to buy) | +500,000 | 500,000 | ||
| 2024-06-14 | CARUSO JAMES V President and CEO | Grant or award · Stock option (right to buy) | +900,000 | 900,000 | ||
| 2024-06-14 | Kolean Chad J Chief Financial Officer | Grant or award · Stock option (right to buy) | +290,000 | 290,000 | ||
| 2024-06-14 | Shustov Andrei Senior Vice President, Medical | Grant or award · Stock option (right to buy) | +260,000 | 260,000 | ||
| 2024-06-14 | Lea Darrell Shane Chief Commercial Officer | Grant or award · Stock option (right to buy) | +260,000 | 260,000 | ||
| 2024-06-14 | Loren Stefan Director | Grant or award · Stock option (right to buy) | +60,000 | 60,000 | ||
| 2024-06-14 | Swirsky Douglas J Director | Grant or award · Stock option (right to buy) | +90,000 | 90,000 | ||
| 2024-06-14 | NEIS JOHN Director | Grant or award · Stock option (right to buy) | +60,000 | 60,000 | ||
| 2024-06-14 | DRISCOLL FREDERICK W Director | Grant or award · Stock option (right to buy) | +60,000 | 60,000 | ||
| 2024-06-14 | Chanan-Khan Asher Director | Grant or award · Stock option (right to buy) | +60,000 | 60,000 |
Page 2 of 6 · 117 trades